Abstract
Methotrexate (MTX) is commonly employed as the initial DMARD used for the treatment of rheumatoid arthritis (RA). We aimed to contribute to the safety profile of MTX by assessing its cumulative effect on renal filtration. A total of 52 RA adult female patients with normal baseline serum creatinine and GFR at the initial diagnosis of the disease were included. Group 1 (G1) included 30 patients (mean age 40.4 ± 4.4 years) on MTX and NSAIDS, while 22 RA patients (mean age 38.5 ± 8.2 years) who received NSAIDs only served as control group (G2). Renal function was assessed by GFR measurement using technetium diethylenetriamine-pentaacetic acid (Tc-99 m DTPA) at a point of the study time corresponding to disease duration. Twenty-one out of thirty (70 %) in G1 showed reduced GFR compared to 6/22 (27.3 %) in G2 (P = 0.007), with 3.3 ± 0.5 % annual reduction in GFR. Reduced GFR in G1 showed significant negative correlation with age (r = −0.396, P = 0.005), MTX cumulative dose (r = −0.263, P = 0.049), MTX-intake duration (r = −0.293, P = 0.031) and NSAIDs-intake duration (r = −0.344, P = 0.014). Low-dose MTX has a slow cumulative effect on renal filtration manifested by GFR reduction overtime that could be monitored by Tc-99 m DTPA.
References
Capkin E, Cakirbay H, Karkucak M et al (2010) Prevalence of rheumatoid arthritis in the eastern Black Sea region of Turkey. Int J Rheum Dis 13:380–384
Karie S, Gandjbakhch F, Janus N et al (2008) Kidney disease in RA patients: prevalence and implications on RA related drug management: the MATRIX study. Rheumatol (Oxford) 47:350–354
Imboden J (2007) Medications. In: Imboden J, HellMann D, Stone J (eds) Current rheumatology diagnosis and treatment, 2nd edn. The McGraw-Hill Companies, Inc, USA, pp 525–528
Weinblatt ME (2001) Methotrexate. In: Ruddy S, Harris ED, Sledge CB (eds) Kelley’s textbook of rheumatology, 6th edn. WB. Saunders Company, Philadelphia, pp 843, 846–849
Rau R, Herborn G (2004) Benefit and risk of methotrexate treatment in rheumatoid arthritis. Clin Exp Rheumatol 22(Suppl 35):S83–S94
Seideman P, Müller-Suur R, Ekman E (1993) Renal effects of low dose methotrexate in rheumatoid arthritis. J Rheumatol 20:1126–1128
Chantler C, Garnett ES, Parsons V et al (1969) Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA. Clin Sci 37:169–180
Harris K, Stribling B (2007) Automated estimated GFR reporting: a new tool to promote safer prescribing in patients with chronic kidney disease? Ther Clin Risk Manag 3:969–972
Perrone RD, Steinman TI, Beck GJ et al (1990) Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The modification of diet in renal disease study. Am J Kidney Dis 16:224–235
Kingdon EJ, Knight CJ, Dustan K et al (2003) Calculated glomerular filtration rate is a useful screening tool to identify scleroderma patients with renal impairment. Rheumatol (Oxford) 42:26–33
Weinblatt ME (1996) Methotrexate in rheumatoid arthritis: toxicity issues. Br J Rheumatol 35:403–405
Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum 31:315–324
Prevoo ML, van’t Hof MA, Kuper HH et al (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthr Rheum 38:44–48
Gates GF (1982) Glomerular filtration rate: estimation from fractional renal accumulation of 99mTc-DTPA (stannous). AJR Am J Roentgenol 138:565–570
National Kidney Foundation Kidney Disease, Outcome Quality Initiative Advisory Board (2002) Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Kidney disease quality initiative: Staging system and action planes for chronic kidney disease. Am J of kidney disease, 39 (suppl 2):SI–246
Coresh J, Auguste P (2008) Reliability of GFR formulas based on serum creatinine, with special reference to the MDRD Study equation. Scand J Clin Lab Invest Suppl 241:30–38
Mohamed RH, Zayed HS, Amin A (2010) Renal disease in systemic sclerosis with normal serum creatinine. Clin Rheumatol 29:729–737
Gutte H, Møller ML, Pfeifer AK et al (2010) Estimating GFR in children with 99mTc-DTPA renography: a comparison with single-sample 51Cr-EDTA clearance. Clin Physiol Funct Imaging 30:169–174
Verstappen SM, Bakker MF, Heurkens AH et al (2010) Utrecht Rheumatoid Arthritis Cohort Study Group. Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy: the CAMERA study. Ann Rheum Dis 69:1044–1048
Townsend RR (2008) Blood pressure raising effects of anti inflammatory drugs, angiogenesis inhibitors, and cholesterol-ester-transfer protein inhibitors. In: Izzo JL, Sica DA, Black HR (eds) Hypertension primer, 4th edn. Lippincott, William and Wilkins, USA, p 46
Harirforoosh S, Jamali F (2009) Renal adverse effects of nonsteroidal anti-inflammatory drugs. Expert Opin Drug Saf 8:669–681
Iqbal MP, Baig JA, Ali AA et al (1998) The effects of non-steroidal anti-inflammatory drugs on the disposition of methotrexate in patients with rheumatoid arthritis. Biopharm Drug Dispos 19:163–167
Fitzgerald GA, Patrono C (2005) The coxibs; selective inhibitors of cyclooxygenase-2. N Engl J Med 345:433–442. In: Cush JJ, Kavanaugh A, Stein CM (eds) Rheumatology diagnosis and therapeutics, 2nd edn. Lippincott Williams and Wilkins, USA, p 494
Daoussis D, Panoulas VF, Antonopoulos I et al (2010) Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis. Ann Rheum Dis 69:517–521
Amann K, Wanner C, Ritz E (2006) Cross-talk between the kidney and the cardiovascular system. J Am Soc Nephrol 17:2112–2119
Acknowledgments
The authors thank Dr. Zeinab Nawito for helpful contributions in the finalization of this work regarding clinical and grammatical aspects.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Amin, A., Effat, D., Goher, N. et al. Tc-99 m diethylenetriamine-pentaacetic acid (DTPA): is it reliable for assessment of methotrexate-induced cumulative effect on renal filtration in rheumatoid arthritis patients?. Rheumatol Int 33, 3059–3063 (2013). https://doi.org/10.1007/s00296-012-2620-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-012-2620-0